AIM IMMUNOTECH INC.
Shares Outstanding
| Period | Shares Outstanding |
|---|---|
| Mar 2017 | 79.4M |
| Mar 2017 | 78.6M |
| Mar 2017 | 78.6M |
| Jun 2017 | 86.9M |
| Aug 2017 | 87.5M |
| Sep 2017 | 93.2M |
| Nov 2017 | 95.3M |
| Dec 2017 | 98.7M |
| Mar 2018 | 138.6M |
| Mar 2018 | 117.7M |
| Jun 2018 | 140.5M |
| Aug 2018 | 141.7M |
| Sep 2018 | 143.9M |
| Nov 2018 | 144.6M |
| Dec 2018 | 3.3M |
| Mar 2019 | 186.9M |
| Mar 2019 | 188.7M |
| May 2019 | 259.9M |
| Jun 2019 | 6.6M |
| Aug 2019 | 6.9M |
| Sep 2019 | 18.3M |
| Nov 2019 | 24.8M |
| Dec 2019 | 31.2M |
| Mar 2020 | 82.9M |
| Mar 2020 | 84.2M |
| May 2020 | 87.6M |
| Jun 2020 | 102.8M |
| Aug 2020 | 119.1M |
| Sep 2020 | 122.1M |
| Nov 2020 | 122.1M |
| Dec 2020 | 126.5M |
| Mar 2021 | 143.5M |
| Mar 2021 | 143.5M |
| Jun 2021 | 143.5M |
| Aug 2021 | 143.5M |
| Sep 2021 | 143.5M |
| Nov 2021 | 143.5M |
| Dec 2021 | 144.0M |
| Mar 2022 | 144.0M |
| Mar 2022 | 144.0M |
| May 2022 | 144.1M |
| Jun 2022 | 144.1M |
| Aug 2022 | 144.1M |
| Sep 2022 | 144.2M |
| Nov 2022 | 144.2M |
| Dec 2022 | 144.3M |
| Mar 2023 | 145.2M |
| Mar 2023 | 145.2M |
| May 2023 | 145.2M |
| Jun 2023 | 145.2M |
| Aug 2023 | 146.0M |
| Sep 2023 | 145.9M |
| Nov 2023 | 146.5M |
| Dec 2023 | 147.3M |
| Mar 2024 | 149.7M |
| Mar 2024 | 148.4M |
| May 2024 | 153.8M |
| Jun 2024 | 158.5M |
| Aug 2024 | 171.4M |
| Sep 2024 | 173.0M |
| Nov 2024 | 191.1M |
| Dec 2024 | 196.6M |
| Mar 2025 | 216.9M |
| Mar 2025 | 211.0M |
| May 2025 | 229.3M |
| Jun 2025 | 2.3M |
| Aug 2025 | 8.1M |
| Sep 2025 | 6.3M |
| Nov 2025 | 8.6M |
| Dec 2025 | 3.1M |
| Mar 2026 | 8.1M |
| Mar 2026 | 4.4M |
| May 2026 | 14.6M |
| Jun 2026 | 17.1M |
| Aug 2026 | 30.4M |